Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Immunome, Inc. (IMNM) had Free Cash Flow per Share of $-2.01 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$9.04M |
|
$-292.96M |
|
-- |
|
$9.04M |
|
$314.84M |
|
$-305.80M |
|
$12.84M |
|
$-292.96M |
|
$-292.96M |
|
$-292.96M |
|
$-292.96M |
|
$-292.96M |
|
$-292.96M |
|
$-305.80M |
|
$-306.60M |
|
58.64M |
|
58.64M |
|
$-5.00 |
|
$-5.00 |
|
| Balance Sheet Financials | |
$221.34M |
|
$10.11M |
|
$18.90M |
|
$240.24M |
|
$54.31M |
|
-- |
|
$4.77M |
|
$59.08M |
|
$181.16M |
|
$181.16M |
|
$181.16M |
|
64.46M |
|
| Cash Flow Statement Financials | |
$-110.79M |
|
$-85.06M |
|
$240.53M |
|
$98.78M |
|
$143.45M |
|
$44.67M |
|
$15.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3382.37% |
|
-3382.37% |
|
-3391.18% |
|
-3240.38% |
|
-3240.38% |
|
$-117.97M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
-- |
|
-- |
|
-161.71% |
|
-161.71% |
|
-121.95% |
|
-161.71% |
|
$2.81 |
|
|
Free Cash Flow per Share |
$-2.01 |
$-1.89 |
|